Healthcare
UFP Technologies, Inc.(UFPT)
Live Price
Offline$234.94
-1.53% today
1Y Change
-0.43%
Window
Jun 20, 2025 โ Jun 15, 2026
- Market Cap
- $1.50B
- Revenue Growth
- +19.5%
- EPS Growth
- +15.3%
- Dividend Yield
- 0.0%
Coverage: 247 bars ยท Jun 20, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
UFP Technologies, Inc. (UFPT) is a Healthcare stock with a market cap of $1.50B and listed on NASDAQ. The stock last traded around $234.94 and down 0.4% across the available one-year price window (Jun 20, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of +19.5%, EPS growth of +15.3%, a dividend yield of 0.0%. What stands out right now is revenue +19.5%, EPS +15.3%, free cash flow +38.7% with operating margin 15.3% and ROIC 12.6%. Valuation is more restrained than many high-expectation growth names at P/E 21.9 and price/sales 2.5. Stock Foundry combines UFPT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+19.5% vs +7.6% peer median
Operating Margin
Below sector median
+15.3% vs +19.4% peer median
P/E
Below sector median
21.9 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 5, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +19.5% and EPS at +15.3%, with operating margin around 15.3%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +2.0% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 5, 2026 | โ | +2.7% | +3.8% | +2.8% |
2026 Feb 24, 2026 | +8.0% | -0.2% | -15.7% | -21.2% |
2025 Nov 3, 2025 | +7.7% | +12.1% | +17.8% | +10.1% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
UFPT
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
UFPT Max Drawdown
-30.69%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for UFPT and SPY.
Company Overview
UFP Technologies, Inc.
NASDAQ Capital Market
UFP Technologies, Inc. designs and custom manufactures components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics primarily for the medical market. Its single-use and single-patient devices and components are used in a range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging. The company also provides engineered products and components to customers in the automotive, aerospace and defense, consumer, electronics, and industrial markets, which are applied in military uniform and gear components, automotive interior trim, athletic padding, environmentally protective packaging, air filtration, abrasive nail files, and protective cases and inserts. It markets and sells its products in the United States principally through a direct sales force, as well as independent manufacturer representatives. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.
- Leadership
- R. Jeffrey Bailly
- IPO Date
- Dec 17, 1993
- Employees
- 4.1k
- Street Address
- 100 Hale Street
- Mailing
- Newburyport, MA, 01950-3504
- Region
- Newburyport, MA, US
- Reporting Currency
- USD
- Investor Line
- 978 352 2200
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 21.9
- EV/EBITDA
- 14.1
- Price/Sales
- 2.5
- Price/Book
- 3.5
Growth
- Revenue
- +19.5%
- EPS
- +15.3%
- Free Cash Flow
- +38.7%
Profitability
- Gross Margin
- 28.3%
- Operating Margin
- 15.3%
- Net Margin
- 11.3%
- ROE
- 17.4%
- ROIC
- 12.6%
Balance Sheet
- Debt/Equity
- 0.36
- Current Ratio
- 2.68
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.